DOSSIER · UPDATED 18 NOV 2025

Moderna

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and…

www.modernatx.com ↗Claim this profile
Founded
2010
Headcount
2,526
Open roles
0
Last raised
Grant · $176M
SECTION I · THE BRIEF

Inside Moderna

Brief #20434Updated 18 NOV 2025CAMBRIDGEMEDICAL ORGANIZATIONSGRANT
Employbl Dossier

Moderna

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious,…

Founded
2010
Headcount
2,526
Open roles
0
Last raised
Grant · $176M
Section II — RestrictedMembers only
  • Tech stack (Moderna engineering primaries)
  • Hiring focus this quarter
  • Interview format & rubric
  • Comp bands by level
  • Decision-makers in talent
  • Recent news & moves
Open Moderna briefSign in

7-day free trial · $25/mo · cancel anytime

TAGS

Categorized in

Company Collections

These are collections Moderna is a part of. Click on the collection name to view similar companies.

Moderna's Industries

Moderna's Tech Stack

LOCATIONS

Where they work

Moderna Headquarters Location

325 Binney Street, Cambridge, MA, 02142

Loading map…
FUNDING

Capital raised

Total Amount Raised: $3,907,600,384

Moderna Funding Rounds

  • Grant

    $176,000,000

  • Grant

    $176,000,000

    Grant Investors

    U.S. Department of Health and Human Services (HHS)

  • Post Ipo Equity

    $750,000,000

  • Post Ipo Equity

    $750,000,000

    Post Ipo Equity Investors

    Blackstone Life Sciences

  • Post Ipo Equity

    $250,000,000

  • Post Ipo Equity

    $250,000,000

    Post Ipo Equity Investors

    MSD Capital

  • Grant

    $472,000,000

  • Grant

    $472,000,000

    Grant Investors

    Biomedical Advanced Research and Development Authority (BARDA)

  • Grant

    $483,000,000

  • Grant

    $483,000,000

    Grant Investors

    Biomedical Advanced Research and Development Authority (BARDA)

  • Series H

    $125,000,000

  • Series H

    $125,000,000

    Series H Investors

    Merck

  • Series G

    $500,000,000

  • Series G

    $500,000,000

    Series G Investors

    ADIA (Abu Dhabi Investment Authority)
    HSG
    Julius Baer
    Alexandria Venture Investments
    Viking Global Investors
    BB Biotech Ventures
    ArrowMark Colorado Holdings
    Pictet Group
    Fidelity
    EDBI

  • IPO

    Unknown

  • Grant

    $8,000,000

  • Grant

    $8,000,000

    Grant Investors

    Biomedical Advanced Research and Development Authority (BARDA)

  • Series F

    $474,000,000

  • Series F

    $474,000,000

    Series F Investors

    AstraZeneca

  • Grant

    $20,000,000

  • Grant

    $20,000,000

    Grant Investors

    Bill & Melinda Gates Foundation

  • Series E

    $450,000,000

  • Series E

    $450,000,000

    Series E Investors

    RA Capital Management
    Viking Global Investors
    Wellington Management
    Invus
    AstraZeneca
    Alexion Pharmaceuticals

  • Corporate Round

    $25,000,000

  • Corporate Round

    $25,000,000

    Corporate Round Investors

    Alexion Pharmaceuticals

  • Series Unknown

    $110,000,000

  • Series Unknown

    $110,000,000

    Series Unknown Investors

    Flagship Pioneering

  • Grant

    $24,600,000

  • Grant

    $24,600,000

    Grant Investors

    Defense Advanced Research Projects Agency (DARPA)

  • Series Unknown

    $40,000,000

  • Series Unknown

    $40,000,000

    Series Unknown Investors

    Flagship Pioneering
Funding info provided by Diffbot.
EMPLOYEE REVIEWS

On the ground at Moderna

Moderna Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Moderna.

Recent reviews